Table 2 Adverse outcome rates according to different diagnostic criteria
Adverse Outcomes | n = 141 | 2018 NICHD definition | 2019 Jensen definition | ||||||
|---|---|---|---|---|---|---|---|---|---|
No BPD (n = 198) | Grade I (n = 52) | Grade II (n = 130) | Grade III (n = 71) | No BPD (n = 198) | Grade 1 (n = 159) | Grade 2 (n = 54) | Grade 3 (n = 40) | ||
Death after 36 weeks’ PMA | 14/141 (9.9) | 0 | 1/52 (1.9) | 2/130 (1.5) | 11/71 (15.5) | 0 | 2/159 (1.3) | 2/54 (3.7) | 10/40 (25.0) |
Hospitalization for respiratory reasons at ≥ 45 weeks’ PMA | 26/141 (18.4) | 0 | 2/51a (3.9) | 13/128a (10.2) | 11/60a (18.3) | 0 | 10/157a (6.4) | 8/52a (15.4) | 8/30a (26.7) |
Oxygen therapy or respiratory monitoring at discharge | 38/141 (27.0) | 3/198 (1.5) | 3/51 (5.9) | 17/128 (13.3) | 15/60 (25.0) | 3/198 (1.5) | 16/157 (10.2) | 9/52 (17.3) | 10/30 (33.3) |
Rehospitalization for respiratory diseases≥2 times | 99/141 (70.2) | 18/198 (9.1) | 12/51 (23.5) | 38/128 (29.7) | 31/60 (51.7) | 18/198 (9.1) | 41/157 (26.1) | 26/52 (50.0) | 14/30 (46.7) |
Late death or serious respiratory morbidity | 141 | 21/198 (10.6) | 15/52 (28.8) | 55/130 (42.3) | 51/71 (71.8) | 21/198 (10.6) | 56/159 (35.2) | 34/54 (63.0) | 30/40 (75.0) |